venous-thromboembolism
(2)
Vahid Saadat
Vahid Saadat is a serial medical device entrepreneur and co-founder and co-CEO of Inquis Medical, a Menlo Park, California company building the AVENTUS Thrombectomy System for treating venous thromboembolic disease and pulmonary embolism. With more than 25 years in medtech and over 200 issued and pending patents, he has founded or led a string of companies including Voyage Medical, USGI Medical, AngioTrax, Baxano and Arrinex (maker of ClariFix, later acquired by Stryker). He holds a BS in Electrical Engineering and an MS in Biomedical Engineering from the University of Texas at Austin, and runs Inquis alongside co-CEO Mojgan Saadat.
Inquis Medical, Inc.
Inquis Medical is a Silicon Valley medical device company founded in 2020 by serial medtech entrepreneurs Vahid and Mojgan Saadat. Its flagship AVENTUS Precision Thrombectomy System removes blood clots from patients with pulmonary embolism (PE) and deep vein thrombosis (DVT), using proprietary TrueClot tissue-sensing technology that gives physicians real-time feedback to distinguish blood, clot, and vessel wall while minimizing blood loss through autologous blood reinfusion. Backed by $115M in total funding including a $75M Series C in January 2026, the company is scaling nationwide commercial adoption after winning FDA 510(k) clearance for PE in 2025.